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CD4 deficiency causes poliomyelitis and axonal blebbing in murine coronavirus induced 1 
neuroinflammation 2 
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ABSTRACT: 12 
Mouse hepatitis virus (MHV) is a murine β-coronavirus (m-CoV) which causes a wide range 13 
of diseases in  mouse and rat, including hepatitis, enteritis, respiratory diseases, and 14 
encephalomyelitis in the CNS. MHV infection in mice provides an efficient cause-effect 15 
experimental model to understand the mechanisms of direct virus induced neural cell damage 16 
leading to demyelination and axonal loss which are pathological features of Multiple sclerosis 17 
(MS), the most common disabling neurological disease in young adults. Infiltration of T 18 
lymphocytes, activation of microglia and their interplay are the primary pathophysiological 19 
events leading to the disruption of myelin sheath in MS. However, there are emerging 20 
evidences supporting gray matter involvement and degeneration in MS. The investigation of T 21 
cell function in the pathogenesis of deep gray matter damage is necessary. Here, we employed 22 
RSA59 (isogenic recombinant strain of MHV-A59) induced experimental neuroinflammation 23 
model to compare the disease in CD4-/- mice with CD4+/+ mice at days 5, 10, 15, and 30 p.i. 24 
Viral titer estimation, nucleocapsid gene amplification and viral anti-nucleocapsid staining 25 
confirm enhanced replication of the virions in the absence of functional CD4+ T cells in the 26 
brain. Histopathological analyses showed an elevated susceptibility of CD4-/- mice to axonal 27 
degeneration in the CNS with augmented progression of acute poliomyelitis, and dorsal root 28 
ganglionic inflammation rarely observed in CD4+/+ mice. Depletion of CD4+ T cells shows 29 
unique pathological bulbar vacuolation in the brain parenchyma of infected mice with 30 
persistent CD11b+ microglia/macrophages in the inflamed regions on day 30 p.i. In summary, 31 
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the current study suggests that CD4+ T cells are critical for controlling acute stage poliomyelitis 32 
(gray matter inflammation) and chronic axonal degeneration, inflammatory demyelination due 33 
to loss of protective anti-viral host immunity. 34 
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IMPORTANCE 46 
The current trend in CNS disease biology is to understand the neural cell-immune interaction 47 
to investigate the underlying mechanism of neuroinflammation, rather than focusing on 48 
peripheral immune activation. Most studies in MS are targeted toward understanding the 49 
involvement of CNS white matter. However, the importance of gray matter damage has become 50 
critical in understanding the long-term progressive neurological disorder. Our study highlights 51 
the importance of CD4+T cells in safeguarding the neurons against axonal blebbing and 52 
poliomyelitis from murine Betacoronavirus-induced neuroinflammation. Current knowledge 53 
of the mechanisms that lead to gray matter damage in MS is limited, because the most widely 54 
used animal model EAE does not present this aspect of the disease. Our results thus, add to the 55 
existing limited knowledge in the field. We also show that the microglia, though important for 56 
the initiation of neuroinflammation, cannot establish a protective host immune response 57 




Neuroinflammation is the cardinal signature of several complex and multi-faceted central 60 
nervous system (CNS) disorders. CNS inflammation is known to be initiated mainly by the 61 
brain’s resident innate immune cells, the microglia, which rapidly respond to an infectious 62 
agent or any perturbation in the CNS. Via the secretion of chemokines and cytokines, they 63 
direct the extravasation of several myeloid cells, including neutrophils, 64 
monocytes/macrophages, and dendritic cells, which in turn promote the entry and activation of 65 
adaptive immune responsive T cell populations into the CNS(1-4).  66 
Regulation of T cells is central to understanding the cellular and humoral immunity in 67 
neuroinflammation. So far, most studies have demonstrated the destructive pathogenic effects 68 
of encephalitogenic T cells in neurodegeneration. For example, Multiple sclerosis (MS the 69 
most common neurological disease of young  adults is characterized predominantly by self-70 
reactive myelinolytic T cell-mediated autoimmune destruction of the myelin sheath (5-10). 71 
Likewise, in an experimental animal model of MS, Experimental autoimmune 72 
encephalomyelitis (EAE), the disease mainly depends on the infiltration of pathogenic CD4+ T 73 
cells, which are primarily of Th1 and Th17 types (11-19). Studies have also shown a pathogenic 74 
role of myelin-specific CD8+ T cells in the inflammatory lesions in EAE mice brains (20-22). 75 
A Mouse hepatitis virus  (MHV) (V5A13.1) model of induced neuroinflammation showed a 76 
significant reduction in the severity of inflammation and demyelination in CD4-/- mice at days 77 
12-21 p.i. compared to both CD8-/- and wild type mice (23). Adoptive transfer of CD4+T cells 78 
and CD8+T enriched splenocytes differentially affect the state of inflammation and 79 
demyelination in MHV-JHM infected RAG-/- mice and induction of donor splenocytes with a 80 
depleted population of both CD4 and CD8+ T cells in JHM infected RAG-/- mice prevents 81 
demyelination (24). However, recent advances have shown that the prevalence of activated 82 
adaptive immune responses are not restricted to neuroinflammatory myelin degeneration as 83 
seen in MS but translates across classic neurodegenerative disorders such as Alzheimer’s 84 
disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS) (25, 26) (27, 85 
28) (29) (30).  86 
With the shift in the paradigm of CNS immunology and the discovery of CNS meningeal 87 
lymphatic vessels, several studies also suggested that CD4+ T cells may provide protective 88 
immunity against cognitive and motor disabilities in neurodegenerative disorders (31) (32). 89 
Activated CD4+ T cells also help in limiting MHV-JHM replication within the CNS (33). Either 90 
CD4 or CD8 deletion in Theiler’s Murine Encephalomyelitis (TMEV) resistant B6 strain 91 
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makes the mice susceptible to disease and shows increased viral persistence and demyelination 92 
(34). The current research trend is thus targeted toward understanding the differential 93 
mechanisms that regulate the balance between neuroprotection and neurodestruction conferred 94 
by CD4+ T cells.  95 
Several studies have demonstrated the accumulation of microglia/macrophages in the vicinity 96 
of reactive CD4+ T cells in CNS lesions during neurodegeneration (4, 30, 35-37). While ample 97 
literature supports CD4+ T cells interaction with CNS resident microglia and/or infiltrating 98 
myeloid-specific monocytes/macrophages as the primary mechanisms underlying white matter 99 
damage in the early relapsing-remitting stage of MS, one cannot overlook their function behind 100 
immune mediated greay matter atrophy. 101 
The current study is focused on understanding the potential protective role of CD4+ T cells on 102 
microglial activation and their cooperative effect on both white and gray matter damage 103 
following infection with a neurotropic isogenic spike protein recombinant strain of 104 
Betacoronavirus MHV, RSA59. Intracranial infection of C57BL/6 mice with RSA59 results in 105 
a biphasic disease, characterized by acute hepatitis and meningoencephalomyelitis followed by 106 
chronic immune-mediated demyelination and concomitant axonal loss, which mimics specific 107 
pathologies of the human demyelinating disease MS (38-40). RSA59 induced acute 108 
neuroinflammation comprises mixed populations of astrocytes and inflammatory cells, mainly 109 
microglia/macrophages and a smaller population of T lymphocytes (40-44). As early as day 3 110 
post-infection (p.i.), peripheral leukocytes start to infiltrate the CNS, beginning with the cells 111 
of the innate immune response predominantly myeloid cells such as neutrophils and 112 
monocytes/macrophages. Lymphoid cells, including CD4, CD8, and NK T cells start to appear 113 
in the CNS at day 5 p.i. and their infiltration peaks at day 7 p.i. followed by the start of viral 114 
clearance (Fig. 1). While CD8+ T cells begin to disappear as early as day 10 p.i. and NK T cells 115 
reduce in number, a significant number of CD4+ T cells are present in the inflamed brain even 116 
at day 16 p.i. (Fig. 1).  While inflammation resolves and infectious virus particles clear from 117 
the brain, Iba1+ macrophages/microglia persist significantly within the demyelinating plaques 118 
in the spinal cord white matter and are known to cause direct myelin stripping (40). Recent 119 
Affymetrix microarray analysis in the spinal cord of RSA59 infected mice showed elevated 120 
expression of inflammatory mediators during the acute stage of infection. Interestingly, 121 
conventional T and B cell markers showed no or insignificant upregulation (45, 46). Expression 122 
of adaptive immune responsive genes showed prominent upregulation during the chronic phase 123 
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(46). The most striking associations were observed between CD3, CD45, and MHCII 124 
expression, which promote the communication between innate and adaptive immune systems 125 
via microglia-CD4+T cell signalling.  126 
Current study employs a CD4 knock out strain in the background of C57BL/6 mice (CD4-/-). 127 
In comparison to the wild type C57BL/6 mice (CD4+/+), infection of CD4-/- mice produces an 128 
exaggerated disease course in association with enhanced viral replication and prolonged viral 129 
persistence. Moreover, CD4-/- mice are more susceptible to chronic inflammation, and axonal 130 
degeneration compared to CD4+/+ mice, and CD11b+ macrophages/microglia show persistent 131 
activation even during the chronic disease phase. Our results suggest a novel neuroprotective 132 
role of CD4+ T cells in the MHV induced demyelinating model of MS unlike the EAE model 133 
where T cells have a predominantly pathogenic role. 134 
RESULTS 135 
Mice were inoculated with isogenic EGFP expressing RSA59 as described in the materials and 136 
methods section. Experimential mice were monitored daily for the development of clinical 137 
signs and symptoms. The majority of CD4+/+ mice displayed low disease scores ranging from 138 
0.5 to 1, indicated by ruffled fur and occasionally  present the hunch back phenotype as 139 
observed previously (47). 100 % mice survived until day 30 p.i as observed . Though not 140 
significantly different, CD4-/- mice showed a slightly higher disease score of 1.5 to 2 indicated 141 
by hind limb weakness in addition to hunch back, the symptoms started appearing as early as 142 
day 3-5 p.i., however, almost 90% mice survived until day 30 p.i. The scoring system has been 143 
discussed in the materials and methods section. 144 
The absence of functional CD4+ T cells does not alter acute stage hepatitis and 145 
meningoencephalomyelitis but shows gray matter involvement in the form of 146 
poliomyelitis and Dorsal Root Ganglion inflammation. 147 
The current study initially investigated differences in phenotypic or pathological symptoms as 148 
well as basal level of inflammation at the tissue level between mock infected CD4+/+ and CD4-149 
/- mice.  No significant differences were observed at the phenotypic level. Conventional light 150 
microscopy data analysis at H& E staining sections from liver, brain and spinal cord revealed 151 
that mock infected (MI) CD4+/+ and CD4-/- mice presented only a basal level of inflammation 152 
(if any) in all the three tissue types (Fig 2). Mock infected CD4-/- mice did not show any 153 
6 
 
differential phenotypic or histopathological features concerned for this study. All experiments 154 
were conducted using  age matched CD4+/+ and CD4-/- mice.  155 
To examine the degree of inflammation in CNS and non-CNS tissues, MI and infected CD4+/+ 156 
and CD4-/- mice were sacrificed at two-time points, day 5-6 p.i. (onset of the peak of 157 
neuroinflammation) and day 30 p.i. (chronic phase of inflammation). The liver, brain, and 158 
spinal cord tissues were harvested and fixed in 4 % paraformaldehyde and paraffin embedded.  159 
During the acute phase of infection, comparable, multiple foci of moderate to severe 160 
necrotizing, and non-necrotizing hepatitis were observed in both CD4+/+ and CD4-/- mice (Fig. 161 
3a). During the chronic phase, hepatitis nearly resolved, but the number of remnant hepatic 162 
lesions were more in CD4-/- mice (Fig. 3b). The Hepatic Activity Index showed no significant 163 
difference at day 6 and 30 p.i. between CD4+/+ and CD4-/- mice (Fig. 3b).  164 
H&E stained brain sections from RSA59 infected CD4+/+ and CD4-/- (Fig. 4a) mice 165 
demonstrated focal acute encephalitis, meningitis, intra-parenchymal perivascular lymphocytic 166 
cuffing, and microglial nodule formation at the acute phase of infection. Corresponding serial 167 
brain sections immunohistochemically stained with anti-CD45 (leukocyte common antigen, 168 
LCA) confirmed similar levels of inflammatory cells in the brain parenchyma of CD4+/+ (2.691 169 
± 0.4561) and CD4-/- (2.485 ± 0.3849) mice(48). H&E staining of both CD4+/+ and CD4-/- (Fig. 170 
4b) infected spinal cords showed myelitis. Quantification of the staining intensity suggests that 171 
corresponding regions were equally immunoreactive for CD45, indicating the comparable 172 
infiltration of mononuclear cells in CD4+/+ (1.176 ± 0.1958) and CD4-/- mice (1.355 ± 0.1947). 173 
However,  the consequent anti-CD11b (pan-macrophage marker) immunohistochemistry 174 
revealed significantly fewer macrophage/microglia in the brains and spinal cords of CD4-/- 175 
mice (0.6067± 0.1260, ****p<0.0001 and 0.258 ± 0.07078, **p<0.01 respectively), as 176 
compared to CD4+/+ mice (4.749 ± 0.3981, and 1.110 ± 0.3007, respectively) (Fig. 5). 177 
Moreover, apart from the white matter myelitis in both infected CD4+/+ and CD4-/- mice, CD4-178 
/- mice showed evidence of acute poliomyelitis (gray matter inflammation) and dorsal root 179 
ganglionic inflammation which were rarely observed in CD4+/+ mice at the acute phase of 180 
infection (Fig. 6). Average inflammation scores,based on H&E, are shown in Table I and II. 181 
The absence of CD4+ T cells impairs RSA59 clearance from the brain tissue. 182 
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To assess the role of CD4+ T cells in virus clearance, viral titer, viral nucleocapsid gene 183 
amplification, in situ viral antigen distribution and mRNA level of anti-viral pro-inflammatory 184 
cytokines /chemokines were evaluated. 185 
RSA59 titer kinetics was compared in the brains of CD4-/- and CD4+/+ mice, and the values 186 
were expressed as log10 PFU/ gram of tissue. In both mouse strains, the virus replicated 187 
efficiently in the brain at day 5 p.i. (105.8 PFU/gm in CD4-/- versus 106.1 PFU/gm in CD4+/+). 188 
By day 10 p.i. CD4-/- mice averaged almost 1-log-higher viral titre (105 PFU/gm versus 103.9 189 
PFU/gm, *p= 0.016) than CD4+/+ mice. On day 15 p.i. there were no detectable viral PFUs in 190 
CD4+/+ mice, however, a significant number of infectious viral PFUs were observed in CD4-/- 191 
mice (104.6 PFU/gm, ****p=0.0001) (Fig. 7a). 192 
To further confirm whether differences in viral replication might affect viral infection, qRT-193 
PCR of viral N-gene (nucleocapsid) from brain tissues from MI, CD4+/+, and CD4-/- infected 194 
mice was performed. As shown in Fig. 7b, viral persistence is comparable in both CD4+/+ and 195 
CD4-/- mice (1.02 fold ± 0.176) at day 5 p.i. At day 10 and day 15 p.i., the N-gene transcript 196 
shows significant upregulation (10.230 folds ± 2.677, **p= 0.003 and 23.247 folds ± 5.204, 197 
****p< 0.0001, respectively), in CD4-/- mice compared to CD4+/+.  198 
To determine the spread of infectious viral particles in situ, immunohistochemical analysis of 199 
viral anti-nucleocapsid antigen was performed on sections of infected brains obtained from 200 
CD4+/+, CD4-/-, and MI mice at the acute and chronic phases of infection. In MI mice, viral 201 
antigen was neither observed at day 6 nor at day 30 p.i. as expected (Fig. 7c). Post-intra-cranial 202 
inoculation, RSA59 replicates profusely in CD4+/+ mice and spreads rapidly from the lateral 203 
geniculate nuclei to several regions of the brain, including the olfactory bulb, basal forebrain, 204 
cerebral cortex, anterior commissure, brain stem and deep cerebellar white matter. By day 6 205 
p.i., viral antigen becomes restricted to the midbrain, pons, and deep cerebellar white matter in 206 
the current study (data not shown). Similar viral anti-nucleocapsid antigen staining was 207 
observed in infected CD4-/- mice at day 6 p.i. Day 30 post infected brains of CD4+/+ mice 208 
showed significantly reduced viral antigen staining as expected, whereas a considerable 209 
number of cells remained positive for viral anti-nucleocapsid antigen in the CD4-/- mice (Fig. 210 
7c). 211 
Moreover,  Interferon gamma (IFN-γ) mRNA expression was significantly higher at day 5 p.i. 212 
in CD4-/- mice (2.45 folds ± 0.59, **p=0.0020), Fig. 7d, in comparison to CD4+/+ mice, 213 
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indicating higher viral replication in CD4-/- mice. Similarly, peripheral leukocyte 214 
chemoattractant IFN-γ inducible CXCL10 (a C-X-C chemokine) mRNA expression remained 215 
significantly upregulated even at day 10 p.i. (5.102 folds ± 1.253, ***p=0.0008) and day 15 216 
p.i. (2.965 folds ± 0.858,*p=0.015)  in the infected CD4-/- mice (Fig. 7e) as compared to CD4+/+ 217 
mice. Also, anti-viral Tumour Necrosis Factor alpha (TNF-α) mRNA expression was observed 218 
to be significantly upregulated at all time points in CD4-/- mice, in comparison to CD4+/+ mice 219 
(6.372 folds ± 1.10, ****p<0.0001 at day5, 37.949 folds ± 9.534,****p=0.00018 at day 10, 220 
and 7.348 folds ± 1.675, ****p<0.0001 at day 15), Fig. 7f. At the same time, CD4-/- mice 221 
displayed lower levels of RANTES (Regulated upon Activation, Normal T Cell Expressed and 222 
Presumably Secreted) or CCL5 (a C-C chemokine, involved in trafficking of 223 
macrophage/monocytes into the CNS) mRNA transcripts at day 5 p.i. (0.523 folds ± 0.124, 224 
**p<0.01 and day 10 p.i. (0.544 folds ± 0.214, *p<0.05) in comparison to CD4+/+ mice (Fig. 225 
7g) 226 
Viral plaque assays and qRT-PCR of viral N-gene and antiviral-cytokines and chemokines 227 
expression (IFN-γ, TNF-α, CXCL10) at day 5, 10 and 15 p.i in corroboration with the viral 228 
anti-nucleocapsid antigen staining at day 30 p.i.  confirmed prolonged persistence of RSA59 229 
in the absence of functional CD4 in brain tissue. 230 
The absence of CD4+ T cells exacerbates CNS inflammation and myelin loss at the chronic 231 
stage of inflammation. 232 
The role of functional CD4+ T cells in demyelination was next examined by histopathological 233 
analysis of day 30 post-infected spinal cords from CD4+/+ and CD4-/- mice.  In CD4+/+ mice, 234 
inflammation was observed in the dorsal/posterior columns, anterior horn and/or the lateral 235 
descending tracts.  H&E staining highlights the inflammation in the ventrolateral white matter. 236 
In contrast, CD4-/- mice demonstrated vacuolar pathology with swollen axons throughout the 237 
white matter, involving the ventral and lateral descending tracts upon H& E staining (Fig. 8a). 238 
Corresponding inflamed regions from serial sections also showed myelin loss by LFB staining 239 
in both CD4+/+ and CD4-/- mice. The degree of demyelination was significantly higher in the 240 
CD4-/- mice (20.45 ± 2.174, ****p<0.0001) compared to CD4+/+ mice (6.008 ± 1.375) (48) 241 
(Fig. 8b). CD45 immunoreactive inflammatory cells were present within the demyelinating 242 
plaques in both CD4+/+ and CD4-/-, however the extent of inflammation was considerably 243 
greater in CD4-/- (2.812 ± 0.1122 ,****p<0.0001) mice in comparison to the CD4+/+ mice 244 
(0.5509 ± 0.08550)   (Fig. 8c).  Interestingly, in contrast to the acute phase of infection, CD4-/- 245 
9 
 
mice (1.237 ± 0.1646, ***p<0.001) spinal cord showed highly significant CD11b 246 
microglia/macrophage expression, in comparison to CD4+/+ mice (0.4175 ± 0.09144). (Fig. 8d) 247 
Quite strikingly, in contrast to the brains of CD4+/+ (Fig. 9a) mice, CD4-/- mice exhibited 248 
extensive vacuolation in the brain stem and the deep cerebellar white matter tracts which has 249 
not been observed in previous studies. No significant differences were observed in CD45 250 
staining between the two groups (Fig. 9b). Large numbers of CD11b positive 251 
microglia/macrophages were observed in the vicinity of the vacuolated regions in CD4-/- mice 252 
(5.251 ± 0.5298, ****p<0.0001) as compared to CD4+/+ mice (2.220 ± 0.1639) (Fig. 9c).  253 
The Absence of CD4+ T cells aggravates axonopathy 254 
One-micron thick sections of glutaraldehyde fixed brains and spinal cords from RSA59 255 
infected CD4-/-, CD4+/+, and MI CD4-/- mice were stained with toluidine blue. MI CD4-/- did 256 
not show any visible signs of inflammation (Fig. 10) or spinal cord damage. Infected CD4-/- 257 
mice exhibited vacuolation and axonal degeneration in the posterior columns (Fig. 11a, b). 258 
Electron microscopy of the vacuolated brainstem lesions in CD4-/- mice revealed that the 259 
vacuolation represents numerous swollen degenerating axons, and few inflammatory cells 260 
(lymphocytes and macrophages). There was no evidence of isolated demyelination (myelin 261 
loss with relative axonal preservation) (data not shown). Similarly, electron micrographs of the 262 
spinal cord white matter lesions (Fig. 11c, d) also showed axonal degeneration and a lack of 263 
demyelination. No inflammatory cells (lymphocytes and macrophages) were present within the 264 
areas of white matter damage (Fig. 11c).  265 
In the absence of CD4+ T cells, mice show differential expression of inflammatory 266 
cytokines. 267 
The inflammatory cells in the demyelinating lesions induced by RSA59, exhibit variable 268 
expression of pro- and anti-inflammatory cytokines. Expression of pro-inflammatory IL-6, IL-269 
12p40, and anti-inflammatory IL-10 were examined in RSA59 infected mouse brains. 270 
Quantitative PCR results revealed that IL-6 expression was significantly higher in CD4-/- 271 
compared to CD4+/+ mice both at day 5 (6.742 folds ± 1.955, ****p<0.0001) and day 10 p.i. 272 
(4.24 folds ± 0.912, ****p<0.0001), and subsequently declines at day 15 p.i. in both groups of 273 
mice (Fig. 12a).   IL-10 expression patterns, as revealed by real-time PCR, showed similar 274 
expression in the RSA59 infected CD4+/+ and CD4-/- mice at day 5 p.i. However, at days 10 275 
(2.579 folds ± 0.72, **p=0.003) and 15 p.i. (2.58 folds ± 0.363, ****p<0.0001) CD4+/+ mice 276 
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showed significantly elevated expression of IL-10 compared to infected CD4-/- mice (Fig. 12b). 277 
IL-12p40 mRNA expression demonstrated no considerable differences between CD4+/+ and 278 
CD4-/- mice following RSA59 infection (data not shown). Together the expression patterns of 279 
IL-6 and IL-10 indicate a robust inflammatory environment in the brains of CD4-/- mice.  280 
The absence of CD4+ T cells influences macrophage polarization. 281 
Using the classical M1/M2 nomenclature of macrophage polarization, it was observed that 282 
mRNA expression of classical M1 macrophage (pro-inflammatory) markers such as CD86 283 
andBruton's tyrosine kinase (Btk) were significantly reduced in infected CD4-/- mice in 284 
comparison to CD4+/+ mice at day 5 p.i (0.445 folds ± 0.128, ***p<0.001 and 0.545 folds ±  285 
0.134, **p<0.01, for CD86 and Btk respectively) (Fig. 12c.d). But, as the course of disease 286 
progressed toward the chronic phase, microglia/macrophages in the infected CD4-/- mice 287 
showed an M2 phenotype (anti-inflammatory) in contrast to the CD4+/+ mice, as observed by 288 
the significant upregulation in the mRNA expression of M2 macrophage marker CD163 at day 289 
15 p.i. (2.018 folds ± 0.392,****p<0.0001) (Fig. 12e). 290 
DISCUSSION 291 
The CNS is no longer considered an immune-privileged site (49). A significant number of 292 
peripheral CD4+ T cells patrol the cerebrospinal fluid (CSF) in order to detect the presence of 293 
potential harmful pathogens (50-52). If these T cells do not encounter their cognate antigen, 294 
they take the lymphatic route to exit the CNS.  However, they will infiltrate the CNS 295 
parenchyma upon sensing any sign of neuroinflammation (52, 53). MHV infection in mice is 296 
an established archetype animal model used to understand the demyelination pathology in MS. 297 
In this study, we present a protective role of CD4+ T cells in the viral induced 298 
neuroinflammatory demyelination, in contrast to the pathogenic role of CD4+T cells in MS(54) 299 
and its autoimmune experimental model EAE. Activated myelinolytic CD4+ T cells have been 300 
observed in the blood and cerebrospinal fluid (CSF) of MS patients (7); Additionally, MS 301 
lesions have been widely associated with the presence of both CD4+ and CD8+ T cells 302 
(55).These autoreactive T cells induce a Th-1 response, majorly targeted against PLP, and can 303 
worsen the disease progression in the patients (56-58). Considering their well-304 
acceptedpathogenic role in MS, classical immuno therapies are devised to silence the CD4+ T 305 
cell mediated attack on the myelin to repair the damage caused to the myelin sheath. Our study 306 
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highlights a quite opposite, protective role of CD4+T cells in a virus induced etiology of 307 
demyelination in MS. 308 
In this study, we present evidences to show that spatio-temporal infiltration of CD4+ T cells in 309 
the CNS and their dynamic equilibrium with brain resident microglia may influence the 310 
progression, severity, and amelioration of white and gray matter inflammation in a neurotropic 311 
virus model. The most widely used experimental model of MS, EAE, holds good only for 312 
understanding the mechanisms of white matter injury and does not recapitulate the aspects of 313 
gray matter damage.   314 
The RSA59-induced demyelinating model is unique, it involves both white and gray matter 315 
inflammation. The onset of the disease is initiated via orchestration of innate immune genes in 316 
the acute phase to clear the virus and restore homeostasis and then gradually progress via 317 
adaptive immunity during the chronic phase (45). RSA59 induced demyelination is dissimilar 318 
to other conventional demyelinating models that are explicitly driven by adaptive immune 319 
responses, with its array of specialized T cells (CD4+ and CD8+) and myelin antigen-specific 320 
antibodies (20, 59, 60). Dynamic host immune responses involving CD4+ helper T cells are 321 
needed for recovery from infections. While CD4+ T cells are helpers for the development of a 322 
complete adaptive immune response, they are also required for enhancing innate immune 323 
effector functions. To assess the role of CD4+ T cells in the innate and adaptive immune 324 
responses and their interactions with microglia/macrophages following RSA59 infection, the 325 
current study compared CD4-/- mice and wild-type mice. The results showed a critical role of 326 
CD4+ T cells in the pathogenesis of RSA59 induced neuroinflammation. We observed the 327 
following: i) Absence of CD4+ T cells caused no change in acute encephalitis; but CD4-/- mice 328 
showed a significant reduction in CD11b positive microglia/macrophages; ii)  viral replication 329 
was higher and viral trancripts were persistent in CD4-/- mice, even at day 30 p.i.; iii) CD4-/- 330 
mice showed an augmented susceptibility toward chronic phase encephalitis and 331 
demyelination. Furthermore, CD4-/- mice, presented with poliomyelitis, bulbar (brainstem) 332 
vacuolation of the neuropil, and dorsal root ganglionic inflammation, a finding rarely observed 333 
in CD4+/+ mice; iv) a strikingly higher number of CD11b positive microglia/macrophages were 334 
present in the CD4-/- mice at the chronic infection phase. These microglia/macrophages were 335 
disseminated throughout the inflamed regions of white matter and in the areas of gray matter, 336 
both in the brain and spinal cord at the chronic infection phase; and v) Electron microscopy 337 
revealed axonal degeneration in the spinal cords of CD4-/- mice even in the absence of 338 
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inflammation, suggesting that white matter degeneration occurs secondary to neuronal injury 339 
without a direct attack of inflammatory cells upon spinal cord myelin sheaths.  340 
Our results also revealed substantially higher mRNA expression levels of IFNγ, TNFα, and 341 
IFN inducible leukocyte chemoattractant CXCL10 in the CD4-/- mice in comparison to CD4+/+ 342 
mice which is likely a response to recruit further peripheral lymphocytes into the CNS to 343 
combat the persistent viral load in the former. The increased and uncontrolled viral replication 344 
contributes to severe inflammation and neuronal cell body damage observed in the gray matter 345 
of the spinal cord and dorsal root ganglion of the CD4-/- mice. Elevated mRNA levels of pro-346 
inflammatory cytokine IL-6 at day 5 and 10 p.i. along with persistent viral load signifies a 347 
robust pro-inflammatory environment in the CNS of CD4-/- mice. Expression of the anti-348 
inflammatory cytokine IL-10 remains almost constant throughout the study in CD4+/+ mice, 349 
while its expression in CD4-/- is consistently low, suggesting that CD4+ T cells serve as one of 350 
the key sources of IL-10 production.  351 
Apart from this, it was interesting to note that anti-viral chemokine CCL5 or RANTES 352 
(macrophage/monocyte chemoattractant) was downregulated in CD4-/- mice at day 5 and 10 353 
p.i., perhaps as a result of which a significant reduction in CD11b positive inflammatory cells 354 
was observed in the brains and spinal cords at the acute phase of inflammation. Nevertheless, 355 
overall encephalitis at the acute phase, as shown by CD45 staining, was comparable in both 356 
CD4+/+ and CD4-/- mice, suggesting that the initial inflammation in the CNS is independent of 357 
CD4++ T cells. This finding also hints that the fewer numbers of CD11b+ cells might be the 358 
result of dampened infiltration of monocyte/macrophages in the absence of functional CD4+ T 359 
cells and the CD11b+ cells observed in the CNS might correspond to the brain resident 360 
microglia.  361 
The function and role of microglia as mediators of homeostasis in the CNS is well established 362 
(61). They not only act as custodians of CNS immunity but also protect neurons during 363 
development and monitor synaptogenesis (62). However, during pathological conditions, 364 
microglia attain a signature pro-inflammatory state that is directed toward the clearance of toxic 365 
substances from the CNS (63, 64). M1 or classically activated microglia can also induce the 366 
activation of A1 astrocytes, which develop altered ability to promote neuroprotection (65). A2 367 
astrocytes are activated by M2 microglia (alternatively activated) and help in CNS repair and 368 
protection (66). Examination of mRNA expression revealed a higher expression of pro-369 
inflammatory M1 markers CD86 and Btk in the CNS of CD4+/+ mice during the acute infection. 370 
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CD163 mRNA transcripts increased in expression in the CD4+/+ mice during day 10 p.i. and 371 
then declined with the restoration of homeostasis, but CD4-/- mice showed a significant increase 372 
in the expression of CD163 mRNA even at day 15 p.i. suggesting that the CD11b+ 373 
microglia/macrophages present during the transition phase (from acute to chronic) in the CNS 374 
might be of the M2 phenotype (anti-inflammatory) attempting to combat the prolonged viral 375 
persistence and restore homeostasis to prevent further tissue damage, but fail to do so without 376 
the help of CD4+T cells. Though M2 microglia/macrophages are categorized as anti-377 
inflammatory, they are also reported to have high phagocytic ability. Their activation and 378 
persistence might, therefore, promote direct myelin stripping as previously reported (40) 379 
leading to significantly greater demyelination and axonal loss in the CD4-/- mice.  380 
An interesting question that remains to be answered is if the infiltration of 381 
monocyte/macrophages is impeded in the first place, why is there a higher expression of CD11b 382 
positive cells in the CNS of CD4-/- mice during the chronic phase? To answer this, future 383 
experiments are aimed at performing immunophenotyping of the inflammatory cells, using 384 
flow cytometry in the CD4-/- mice, to explicitly decipher whether the cells present at the chronic 385 
phase are predominately peripherally recruited monocytes/macrophages or the activated 386 
resident phagocytic microglial cells of the CNS. So far, flow cytometric analysis in CD4+/+ 387 
mice has shown the presence of a significant population of CD11b hi/ CD45 lo (microglia) at 388 
day 30 p.i. but very little or no CD11b expressing CD45 high monocyte/macrophages in the 389 
CNS (data not shown). We, therefore, expect the CD11b+ cells found in the CNS at day 30 in 390 
the CD4-/- mice to be microglia and not peripherally recruited myeloid cells.  391 
For this study, we have opted for a mouse strain (B6.129S2-Cd4tm1Mak/J) where the 392 
functionality of CD4+ T helper cells was disrupted. The development of CD8+ T cell and 393 
myeloid components was unaffected. 90% of the circulating T cells were CD8+  and their 394 
cytotoxic activity was within normal ranges (67). Despite the presence of functional CD8+ T 395 
cells, viral clearance was substantially delayed. Thus, our studies suggest a vast preponderance 396 
of CD4+ T cells over CD8+ T cells in maintaining the homeostasis upon RSA59 induced 397 
neuroinflammation. 398 
In conclusion, our results demonstrate that CD4+ T cells are necessary for eliminating viral 399 
particles, promoting microglial polarization toward anti-inflammation, and controlling chronic 400 
progressive axonal degeneration. The current study also highlights the importance of CD4+T 401 
cells beyond the classic inflammatory lesions of the white matter tract. We have shown that 402 
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gray matter inflammation in the form of poliomyelitis is significantly exacerbated in the 403 
absence of CD4+ T cells. Moreover, we show that the imprinting of the microglia/macrophage-404 
mediated inflammatory innate immune response on the consequent protective adaptive 405 
immunity requires functional CD4+ T cells. This communication between microglia and T cells 406 
is a highly regulated, interdependent, and bidirectional process and is critical for the 407 
establishment of an effective immune response. Although innate anti-viral immune responses 408 
by microglia are crucial in controlling the initial CNS viral dissemination, virus-specific T cells 409 
are essential to eliminate the virus and provide indispensable neuroprotection. Further studies 410 
will be conducted to understand the nexus between CNS resident microglia/monocyte-derived 411 
macrophages with infiltrating activated T helper cells at the molecular level through immune-412 
coregulatory CD40-CD40 ligand (L) pathway. This dyad is broadly recognized for its essential 413 
role in immune regulation and homeostasis. Our studies will be focused to examine such 414 
interactions at the molecular level using CD40 and CD40L deficient mice in the outcome of 415 
inflammatory demyelinationMost MS therapies are aimed at preventing damage to myelin by 416 
regulating the multiple components of adaptive immune system,especially the T cell subsets 417 
(Th1, Th2, Th17, CD8+, NKT, CD4+CD25+ T regulatory cells) and B cells. Current therapies 418 
have only been able to reduce the number and rate of MS lesion formation and are only partially 419 
efficacious(68). Understanding the role of T cells in  a viral induced model of MS is thus critical 420 
to design more robust therapeutics. Together these studies can help to expand our knowledge 421 
intended to use CD4 mediated immune therapy as a potential treatment of MS, depending on 422 
its etiologyand the initiation of the pathology.  423 
MATERIALS AND METHODS 424 
Virus, Inoculation of mice and Experimental design  425 
Recombinant isogenic demyelinating (DM) strain of MHV-A59, RSA59, was used to infect 426 
mice as formerly described (39). Four to five-week old, MHV-free, CD4+/++/+ C57BL/6 (B6) 427 
mice (Jackson Laboratory) and CD4-/- (B6.129S2-Cd4tm1Mak/J) mice (Jackson Laboratory, 428 
Stock no. 002663) were used for the study. The CD4-/- mice obtained from Jackson’s laboratory 429 
is homozygous for the Cd4tm1Mak targeted mutation, have a significant blockade in the CD4+ T-430 
cell development and show an MHC class II restricted T helper cell activity(67). The mice 431 
were inoculated intracranially with 25,000 (50% of LD50) PFU of RSA59 strain as described 432 
previously. Likewise, mock-infected controls for CD4+/+ and CD4-/--/- mice were inoculated 433 
with an uninfected cell lysate (PBS+0.075% BSA) at an equivalent dilution. Mice were 434 
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monitored daily post infection (p.i.) for disease signs and symptoms. Clinical disease severity 435 
was graded using the following scale: 0, no disease symptoms; 1, ruffled fur; 1.5, hunched back 436 
with mild ataxia: 2, Ataxia, balance problem and hind limb weakness: 2.5 one leg completely 437 
paralyzed, motility issue but still able to move around with difficulties; 3, severe 438 
hunching/wasting/both hind limb paralysis and mobility is severely compromised;3.5 Severe 439 
distress, complete paralysis and moribund 4, dead (47). 440 
For EM, histopathological, and immunohistochemical analyses mice were sacrificed at the 441 
acute infection phase, i.e. on day 5-6 (four mice per group), and chronic infection phase, i.e. 442 
day 30 (five mice per group) post-infection. For RNA and protein studies and viral titer 443 
estimation, animals were sacrificed (3 mice per group) on days 5, 10 and 15 post-infection. 444 
Estimation of Viral Replication 445 
Mice were euthanized on days 5, 10 and 15 post-infection and perfused transcardially with 20 446 
ml of sterile PBS. Brains were harvested for determination of viral titers and placed into 1 ml 447 
of isotonic saline containing 0.167% gelatin (gel saline). Brain tissues were weighed and kept 448 
frozen at -80°C until titred. Tissues were subsequently homogenized, and viral titers were 449 
quantified by standard plaque assay protocol on tight monolayers of L2 cells as described 450 
previously with minor modifications (39). 451 
Histopathology and Immunohistochemical Analysis 452 
Mice were sacrificed at day 6 and day 30 post-infection. Following transcardial perfusion with 453 
PBS and 4% paraformaldehyde, liver, brain, and spinal cord tissues were harvested and 454 
embedded in paraffin. Five-micron thick sections of the embedded tissues were prepared and 455 
stained with Hematoxylin and Eosin for histopathologic analysis. Luxol fast blue (LFB) 456 
staining was performed to evaluate demyelination in the brain and spinal cord tissues, as 457 
described previously with minor modifications (40). 458 
Immunohistochemical staining of brain and spinal cord tissue sections used the following 459 
primary antibodies - 1:10000 dilution of anti-CD11b (Abcam, Cat #:ab133357), 1:200 dilution 460 
of anti-CD45 (LCA; leukocyte common antigen, BD Pharmingen Cat#:550539) and 1:40 461 
dilution of monoclonal antibody directed against the nucleocapsid protein (N) of MHV 462 
(monoclonal antibody clone 1-16-1 provided by Julian Leibowitz, Texas A&M University).  463 
Bound primary antibodies were detected by an avidin-biotin immunoperoxidase technique 464 
16 
 
(Vector Laboratories) using 3, 3-diaminobenzidine as the substrate. Control slides from mock-465 
infected mice were stained in parallel. All slides were coded and read in a blinded manner by 466 
the same investigator, as described previously with minor modifications (40).  467 
H&E Sections were assessed for inflammation in the following manner: 0, none; 1, few 468 
inflammatory cells; 2, organization of perivascular infiltrates; and 3, increasing severity of 469 
perivascular cuffing and formation of microglial nodules, and represented in Table 1 (47).  470 
Quantification of histopathological sections 471 
The number of hepatic lesions were counted per section and averaged for each mouse at each 472 
time point (both acute and chronic phase of inflammation). The functional scoring of the 473 
inflammatory lesions in the liver was characterized as the Hepatic activity index (HAI). Degree 474 
of activity was categorized as portal inflammation; Interphase hepatitis (Piecemeal necrosis); 475 
Focal (Spotty) necrosis, apoptosis, and focal inflammation; and Confluent necrosis. Scores 476 
from 0-6 were allotted for each category based on the modified Knodell’s HAI, commonly 477 
referred to as the Ishak system (69). 478 
Image analysis was performed using the basic densitometric thresholding application of Fiji 479 
(Image J, NIH Image, Scion Image) as described previously (48). Briefly, image analysis for 480 
CD45 and CD11b stained sections was performed by capturing the images at the highest 481 
magnification (4X-for brain, 10X-for spinal cord) such that the entire section (i.e., scan area) 482 
can be visualized within a single frame. The RGB image was deconvoluted into three different 483 
colours to separate and subtract the DAB-specific staining from the background H&E staining. 484 
The perimeter of each brain and spinal cord tissue was digitally outlined, and the area was 485 
calculated in µm2. A threshold value was fixed for each image to make sure that all antibody 486 
marked cells are taken into consideration. The amount of CD45, and CD11b staining was 487 
termed as the ‘% area of staining’. 488 
To determine the area of demyelination, LFB-stained spinal cord cross-sections from each 489 
mouse were chosen and analyzed using Fiji software (Image J 1.52g). The total perimeter of 490 
the white matter regions in each cross-section was marked and calculated by adding together 491 
the dorsal, ventral and anterior white matter areas in each section. Also, the total area of the 492 
demyelinated regions was outlined and collated for each section separately. The percentage of 493 
spinal cord demyelination per section per mouse was calculated. 494 
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Gene Expression: RNA Isolation, Reverse transcription and quantitative Polymerase 495 
chain reaction  496 
RNA was extracted from brain tissues (flash-frozen) of RSA59 infected CD4+/+ and CD4-/- and 497 
mock-infected mice (3 from each group at days 5, 10 and 15 p.i.) using the Trizol isolation 498 
protocol following transcardial perfusion with DEPC treated PBS. The total RNA 499 
concentration was measured using a NanoDrop ND-100 spectrophotometer. 1µg of RNA was 500 
used to prepare cDNA using a High Capacity cDNA Reverse Transcription Kit (Applied 501 
Biosystems). Quantitative Real-time PCR analysis was performed using DyNAmo Color Flash 502 
SYBR Green qPCR kit (Thermo Scientific) in a Step One plus Real-time PCR system (Thermo 503 
Fisher Scientific) under the following conditions: initial denaturation at 95°C for 7 min, 40 504 
cycles of 95°C for 10 s, 60°C for 30 s, melting curve analysis at 60°C for 30 s. Reactions were 505 
performed in triplicate. Sequences for the primers used are given in Table III. Relative 506 
quantitation was achieved using the comparative threshold (∆∆Ct) method. mRNA expression 507 
levels of target genes in RSA59 infected CD4+/+ and CD4-/- mice were normalized with β-Actin 508 
and expressed as relative fold change compared to their respective mock-infected controls.  509 
Ultra-structural studies and electron microscopy to characterize the preservation of 510 
myelin and axons 511 
To characterize axonal blebbing, disruption of the myelin sheath, and axon-myelin coherence, 512 
ultrastructural studies were carried out on the brains, brainstem and spinal cords of mice. 513 
Infected CD4-/-, CD4+/+ and CD4-/- mock-infected mice were anesthetized and sacrificed at day 514 
28 p.i. Mice were perfused with 4% PFA.  Brains and spinal cords were harvested and fixed 515 
overnight in 2% glutaraldehyde, post-fixed with 1% osmium tetroxide, and dehydrated in a 516 
graded series of ethanol washes. For transmission electron microscopy, samples were flat 517 
embedded in Poly-Bed 812 epoxy resin (Polysciences) and sectioned (500 nm) from the 518 
lesional epicenter. Toluidine blue staining was performed for examination by light microscopy. 519 
Ultrathin TEM sections (600 Å) were trimmed from the representative foci of interest from 520 
toluidine blue-stained sections and mounted on 200 mesh copper grids, stained with uranyl 521 
acetate and bismuth subnitrite, and viewed under a JEOL JEM 1010 electron microscope (40). 522 
Statistical Analyses 523 
The viral titer was calculated as plaque-forming units (PFU) based on the following formula = 524 
(no. of plaques X dilution factor/ml/gram of tissue). Virus titer was expressed as log10 525 
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PFU/gram of tissue. Quantitative RT-PCR data were presented as mean values ± SEM. Values 526 
were subjected to Two-Way ANOVA/Student’s t-test analysis for calculating the significance 527 
of differences between the means. Also, multiple comparisons were achieved by the Tukey test 528 
and the Holm-Sidak test. All statistical analyses were done using GraphPad Prism 6 (La Jolla, 529 
CA). A P-value of <0.05 was considered statistically significant. 530 
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FIGURE LEGENDS 758 
Fig. 1. Temporal immune cell kinetics in the brains of RSA59 infected mice. Results from 759 
flow cytometric analysis of the migration of inflammatory cells and CNS resident cells from 760 
the RSA59 infected mice has been summarized in the schematic diagram. The diagram 761 
represents the differential infiltration of total myeloid (neutrophils, macrophage/monocytes and 762 
microglia) and lymphoid (CD4, CD8 and NKT) cell populations during days 3, 5, 7, 10, 16 and 763 
30 p.i. Respective peaks show highest infiltration at times post infection. ScaleArbitrary. 764 
Fig. 2. Absence of CD4 causes no significant pathology in the mock infected mice. CD4+/+ 765 
and CD4-/- mice were infected with with an uninfected cell lysate (PBS+0.075% BSA). 5-766 
micron thick liver,brain and spinal cord sections were stained with H&E and CD45 for routine  767 
histopathological studies. No  inflammation was observed in CD4+/+ and CD4-/- mice tissues. 768 
Data are represented from 3 independent biological replicates.  Scale bars= 50 microns  769 
Fig.3 Absence of CD4 shows no significant alterations in RSA59 induced Liver pathology. 770 
CD4+/+ and CD4-/- mice were infected with RSA59 and 5-micron thick liver sections were 771 
stained with H&E for routine morphological studies. a) Both CD4+/+ and CD4-/- mice showed 772 
similar features of necrotic/non-necrotic hepatitis. Hepatic Activity Index was calculated 773 
according to Ishak’s Score as described in materials and methods and plotted (b). c) The 774 
average number of hepatic lesions were counted per section from each mouse, combined results 775 
were tabulated. Liver sizes and cross-sectional areas were comparable in both CD4+/+ and CD-776 
/- mice.  Data are represented from 5 independent biological experiments. 777 
Fig.4 Absence of CD4 demonstrates no significant changes in encephalomyelitis upon 778 
RSA59 induced acute infection. a, b) At day 6 p.i., sections of brain (panel a) and spinal cord 779 
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(panel b) from CD4+/+ mice and CD4-/- mice were stained with H&E and 780 
immunohistochemically for LCA (leucocyte common antigen). Boxed areas are shown at 781 
higher magnification below the corresponding brain midsagittal sections (panel a) or cross 782 
sections of spinal cord (panel b).  The arrows in the zoomed sections mark characteristic 783 
perivascular cuffing and microglial nodule formation mediated by infiltrating inflammatory 784 
cells in the H&E-stained sections which correspond to immunoreactive leukocytes and 785 
microglia/macrophages in the CD45 immunohistochemically stained sections. Scale bars of 786 
midsagittal brain sections represent 1000 microns whereas they represent 100 microns in the 787 
higher magnification images shown below.  Scale bars of spinal cord cross sections represent 788 
200 microns whereas they represent 50 microns in the higher magnification images shown 789 
below.  Quantification of the intensity of staining is plotted in a scatter diagram. Statistical 790 
analysis was performed using Student’s t-test and Welch correction. Data are represented from 791 
5 independent biological experiments.  792 
Fig.5 Absence of CD4 resulted in a significant reduction of CD11b positive 793 
microglia/macrophages in the brain and spinal cords during RSA59 induced acute 794 
infection. At day 6 p.i., sections of brain and spinal cord from CD4+/+ mice and CD4-/- mice 795 
were immunohistochemically stained for CD11b (macrophage/microglia activation marker). 796 
Boxed areas are shown at higher magnification below the corresponding brain midsagittal 797 
sections (upper panel) or cross sections of spinal cord (lower panel).  Arrows mark 798 
microglia/macrophages in the in the CD11b immunohistochemcally stained sections. Scale 799 
bars of midsagittal brain sections represent 500 microns whereas they represent 200 microns 800 
in the higher magnification images shown below.  Scale bars of spinal cord cross sections 801 
represent 500 microns whereas they represent 200 microns in the higher magnification images 802 
shown below.  Quantification of the intensity of staining is plotted in a scatter diagram. 803 
Statistical analysis was performed using Student’s t-test and Welch correction. ***p<0.001; 804 
****p<0.0001. Data are represented from 5 independent biological experiments. Error bar 805 
represents SEM. 806 
Fig.6 Absence of CD4 results in severe poliomyelitis and dorsal root ganglionic 807 
inflammation during acute RSA59 infection. Sections of CD4+/+ and CD4-/- mouse spinal 808 
cords were stained with H&E and immunohistochemically with anti-CD45. There is increased 809 
inflammation of the gray matter (poliomyelitis) and dorsal root ganglia in CD4-/- as compared 810 
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to CD4+/+ mice.   Mock-infected mice showed no inflammation. All scale bars indicate 90µm. 811 
N=5. 812 
Fig.7 Absence of CD4 results in reduced viral clearance and altered expression of 813 
antiviral effector genes. a) Whole-brain lysates from CD4+/+ and CD4-/- mice at days 5, 10 814 
and 15 p.i. were subjected to comparative viral plaque assays on confluent monolayers of L2 815 
cells. Each time point represents the mean titer for three mice. Titers are expressed as log10 816 
PFU per gram of tissue. b) The relative abundance of transcripts corresponding to viral N-gene 817 
was compared using qRT-PCR in the CD4+/+ and CD4-/- infected mouse brains at days 5, 10 818 
and 15 p.i. c) Anti-N immunohistochemistry revealed the differential in-situ distribution of 819 
viral antigen in the representative anatomical regions (between brain stem and deep cerebellar 820 
white matter) of mock-infected CD4+/+; and RSA59 infected CD4+/+  and CD4-/- mice at days 821 
6 and 30 p.i.. Scale bar 100µm (4X) and 50µm (40X). Relative gene expression of IFN γ (d), 822 
CXCL10 (e), TNFα (f) and CCL5 (g) at days 5, 10 and 15 p.i. were analyzed by qRT-PCR and 823 
compared between CD4+/+ and CD4-/- mice. qRT-PCR results were expressed as fold mean ± 824 
SEM. Statistical analysis of the data represented in panels a, b, d, e, f, and g) was calculated 825 
using Two-way ANOVA, and multiple comparison was achieved by Hom’s Sidak; *p<0.05; 826 
**p<0.01; ***p<0.001; ****p<0.0001. Data are represented from 3 independent biological 827 
experiments, N=3, 3 technical replicates each. 828 
Fig.8 Absence of CD4 leads to severe chronic inflammatory demyelination and axonal 829 
loss. a) Cross-sections of CD4+/+ and CD4-/- mouse spinal cords were analyzed for the presence 830 
of inflammatory lesions by H&E, demyelination by LFB, and inflammatory cells by anti-CD45 831 
and anti-CD11b (microglia/macrophages) immunohistochemistry. Boxed areas are shown at 832 
higher magnification to right of the corresponding spinal cord cross sections.  Arrows mark 833 
demyelinating plaques on the LFB stained sections, infiltrating inflammatory cells in the H&E 834 
stained sections, and immunoreactive leukocytes and microglia/macrophages in the CD45 and 835 
CD11b immunohistochemcally stained sections respectively. Scale bars of spinal cord cross 836 
sections represent 200 microns whereas they represent 50 microns in the higher magnification 837 
images.  Levels of demyelination and inflammation are plotted in a scatter diagram (b, c, d).  838 
Statistical significance was calculated by unpaired Student’s t-test and Welch correction. 839 
***p< 0.001; ****p<0.0001). Data are represented from 4-5 independent biological 840 
experiments. Error bar represents SEM. 841 
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Fig.9 Absence of CD4 causes abnormal bulbar (brainstem) vacuolation and neuronal loss 842 
in RSA59 infected brains at day 30 p.i. a) Serial sagittal sections of brains from both CD4+/+ 843 
and CD4-/- mice were analyzed for inflammation at day 30 p.i. by H&E and 844 
immunohistochemically by CD45 and CD11b. Boxed areas are shown at higher magnification 845 
below the corresponding brain midsagittal sections.  Arrows mark infiltrating inflammatory 846 
cells in the H&E stained sections, and immunoreactive leukocytes and microglia/macrophages 847 
in the CD45 and CD11b immunohistochemcally stained sections respectively. Scale bars of 848 
spinal cord cross sections represent 200 microns whereas they represent 50 microns in the 849 
higher magnification images.  Quantification of inflammation was performed for CD45 (b) and 850 
CD11b (c) staining. The level of significance was calculated by unpaired Student’s t-test and 851 
Welch correction, ****p<0.0001). Error bar represents SEM. Data are represented from 4-5 852 
independent biological experiments. 853 
Fig. 10. Absence of CD4 causes no alteration in the axon-myelin coherence in the brain 854 
stem and spinal cord of mock infected mice. Toluidine blue stained sections of 855 
glutaraldehyde fixed, epoxy resin embedded sections (500 nm thick) from mock infected CD4-856 
/- mouse brain stem (A, B) and spinal cord (C, D).  A.  Gray and white matter of brain stem.  857 
Arrows mark bundles of intact myelinated fibres.  Asterisks mark the neuronal nuclei. Original 858 
magnification – 400X.  B.  Brain stem white matter.  Original magnification - 1000X.  C.  859 
Spinal cord cross section.  Original magnification 40X.  Posterior columns in boxed area are 860 
further magnified in D.  Original magnification 1000X.  White and gray matter in both the 861 
brain stem and spinal cord show no evidence of inflammation, demyelination or cellular injury. 862 
Fig.11 Absence of CD4 results in severe spinal cord axonal injury upon RSA59 infection 863 
at the chronic stage. a and b: Toluidine blue-stained sections. a) Posterior columns (200X) 864 
and b) (1000X) demonstrate clusters of degenerating axons. Arrows - degenerating axons, 865 
asterixes - swollen myelin sheaths.  c and d: Corresponding electron microscopy. c) Swollen 866 
myelin sheaths with loss of axoplasm (7,500X). d) Cluster of degenerating axons with 867 
collapsed myelin sheaths (10,000X). The arrow shows the corresponding area on the toluidine 868 
blue-stained section. Scale bar represents 2 microns. Data are represented from 3 independent 869 
biological experiments. 870 
Fig.12 qRT-PCR analysis of IL-6, IL-10, CD86, Btk and CD163 reveals an inflammatory 871 
state in the brains of RSA59 infected CD4-/- mice. Quantitative PCR analysis of IL-6 (a) IL-872 
10 (b); CD86 (c); Btk (d); CD163 (e) analysis was performed in RSA59 infected CD4+/+ and 873 
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CD4-/- mouse brains at days 5, 10 and 15. Data are represented from 3 independent biological 874 
experiments, N=3, 3 technical replicates each. Statistical analysis was performed by Two-way 875 
ANOVA, Hom Sidak’s multiple comparison test; **p<0.01; ***p<0.001; ****p<0.0001. Error 876 
bar represents SEM. 877 









% mice with 
inflammatio
n 
Mean score of 
Inflammation 
(mean ± SEM) 
Acute phase RSA59 CD4+/+ 4 08 100 % 1.8±0.322 
Chronic phase RSA59 CD4+/+ 5 10 100 % 1.4±0.163 
Acute phase RSA59 CD4-/- 4 08 100% 2.0±0.189 
Chronic Phase RSA59 CD4-/- 4 10 100% 2.5±0.189 
Significant difference was  observed only at the chronic phase of infection between CD4+/+ 880 
and CD4-/- brains (***p=0.0004) 881 
Table II. Average Inflammation score in RSA59-infected CD4+/+ and CD4-/- mouse 882 








% mice with 
inflammatio
n 
Mean score of 
Inflammation 
(mean ± SEM) 
Acute phase RSA59 CD4+/+  3* 20 80 % 0.6±0.112 
Chronic phase RSA59 CD4+/+ 5 30 100 % 0.76±0.114 
Acute phase RSA59 CD4-/- 4 20 100% 1.1±0.143 
Chronic Phase RSA59 CD4-/- 4 20 100% 1.05±0.05 
*1 mouse was an outlier; it did not get infected. 884 
Table III. List of Primers 885 
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Gene Forward 5’-3’ Reverse 5’-3’ 







TNF α CTGTAGCCCACGTCGTAGC TTGAGATCCATGCCGTTG 
CCl5 CCA ATC TTG CAG TCG TGT TTG 
T 
CAT CTC CAA ATA GTT GAT 
GTA TTC TTG AAC 
CXCL10 GACGGTCCGCTGCAACTG CTTCCCTATGGCCCTCATTCT 
Btk1 ACAGCAGAACACATTGCTCA GGGAACTCCTCAGGAAACAT 
IL12 p40 GGAAGCACGGCAGCAGAATA AACTTGAGGGAGAAGTAGGAA
TGG 
IL6 AGTTGCCTTCTTGGGACTGA TCCACGATTTCCCAGAGAAC 
IL10 AGTGGAGCAGGTGAAGAGTG TTCGGGAGAGGTACAAACG 
Anti -N AGGATAGAAGTCTGTTGGCTCA GAGAGAAGTTAGCAAGGTCCT
ACG 
GAPDH GCCCCTTCTGCCGATGC CTTTCCAGAGGGGCCATCC 
Β- Actin CTTCTACAATGAGCTGCGTGTG GGTCTCAAACATGATCTGG 
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